iiinova — where your digital self keeps evolving

Reposted by David Liew

Mwidimi Ndosi @ndosie.bsky.social · 07/01/2026

Palindromic rheumatism is unpredictable and under-researched New study by Chapman et al captures valuable patient insights ➡️ Unpredictable flares & psychological distress ➡️ Frequent diagnostic delays ➡️ Lack of info on progression to RA @rheumjnl.bsky.social #palindromic doi.org/10.1093/rap/...

doi.org

Living with palindromic rheumatism: a qualitative interview study

AbstractObjectives. Palindromic rheumatism (PR) is an unpredictable and under-researched inflammatory condition, and patients with PR are at risk of develo

053

Reposted by David Liew

Dr. John Cush @rheumnow.bsky.social · 31/10/2025

Upadacitinib is a Double Edged Vascular Sword in GCA Dr. David Liew discusses abstracts O751, O738, and O734 presented at #ACR25. buff.ly/e1fS13D

011

David Liew @drdavidliew.bsky.social · 30/06/2025

Latest atlas article out @rheumjnl.bsky.social Rheumatology Advances in Practice: Imaging of gout (an area with lots of nuance) very pretty images but also lots of great practical hints from Luqman Wali & Emma Rowbotham Well worth checking out & it's open access: academic.oup.com/rheumap/arti...

021

David Liew @drdavidliew.bsky.social · 23/06/2025

Why does it seem like PMR patients get stuck in situations we would never tolerate for other patients? @drceowen.bsky.social and I call out many reasons. PMR is killing them softly, and will continue to do so if collectively we neglect it. now out @thelancetrheum.bsky.social: t.co/wMOy9ZEzw4

162

Reposted by David Liew

The Lancet Rheumatology @thelancetrheum.bsky.social · 20/06/2025

NEW RESEARCH—Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from the phase 3 SAPHYR trial bit.ly/4k0mlJQ Plus linked Comment by @drdavidliew.bsky.social & @drceowen.bsky.social bit.ly/4eiha6W #Medsky #Rheumsky

041

David Liew @drdavidliew.bsky.social · 12/06/2025

Sometimes you hear: “PMR dose steroids don’t really matter” Errrrr… (You wouldn’t accept this steroid exposure in any other disease. Never) #EULAR2025 POS0139 @rheumnow.bsky.social

070

David Liew @drdavidliew.bsky.social · 12/06/2025

Fast track PMR clinics in Denmark led to more patients seen, and time to referral went down. If we don’t get in early with a right diagnosis (and maybe early steroid-sparing) then PMR patients deteriorate. We shouldn’t let PMR be an end stage disease #EULAR2025 POS0136 @rheumnow.bsky.social

041

David Liew @drdavidliew.bsky.social · 11/06/2025

Oh and in case you’re forward planning to #EULAR2026 - it’s London, 3-6 June. Right now it might be just the start of #EULAR2025, but start your trip planning now! @RheumNow

060

David Liew @drdavidliew.bsky.social · 11/06/2025

IL-17 inhibition for PMR? In the secukinumab ph2 in GCA (TitAIN), patients with PMR did really well, seemingly outperforming steroid taper in the placebo arm. Real promise, will be great to see how the ph3 in PMR (REPLENISH) goes OP0062 #EULAR2025 @rheumnow.bsky.social

041

David Liew @drdavidliew.bsky.social · 11/06/2025

What’s worse for infection in GCA: tail end steroid taper, or a JAK inhibitor? This is exactly SELECT-GCA in the second 6mo. What happened? upa skews better on serious infection, worse on HZ JAKi might have infection risk, but not like steroids. OP0057 #EULAR2025 @rheumnow.bsky.social

020

David Liew @drdavidliew.bsky.social · 11/06/2025

Here in Barcelona, and back at it for the @RheumNow team! Bring on #EULAR2025 and all the great rheumatology here Of course with the dynamic team of @synovialjoints @Yuz6Yusof @DrMiniDey @AurelieRheumo @AdelaCastro222 @JihaRheum @Nellziade and the one and only @Janetbirdope

050

David Liew @drdavidliew.bsky.social · 03/04/2025

GCA finally gets a second option, eight years after the first! Choice means more people can get benefit, but also that we can start to look at strategy - something we badly need for both GCA and PMR.

030

Reposted by David Liew

JAMA @jama.com · 02/12/2024

Text message reminders targeting patients who delay refilling their cardiovascular medications did not improve medication adherence based on pharmacy refill data or reduce clinical events at 12 months. ja.ma/4irtinM

06724

Reposted by David Liew

Dr. John Cush @rheumnow.bsky.social · 02/12/2024

Ozempic will change rheumatology Ozempic's presence is widespread, even reaching Australia, despite limited supply and advertising restrictions. Its American ad jingle is known here, highlighting its significant cultural impact and ubiquitous brand recognition.

buff.ly

Ozempic will change rheumatology | RheumNow

Many of our diseases are made worse by obesity, notably rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Much of the refractory pain and suffering from these conditions might be…

011